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Long-term follow-up of any patient cohort constitutes one of 
the most valuable learning tools in medicine. It is both 
fortunate and laudable that the earliest workers (I) in the 
field of coronary angioplasty have tracked their initial expe- 
rience and can now provide outcome data after a full decade 
of follow-up (1). We need such information about a proce- 
dure that has burgeoned beyond the quarter million mark 
annually and now accounts for approximately 50% of all 
cardiac revascularization procedures performed inthis coun- 
try. 
The present s udy. Until the present report by Webb et 
al. (1) in this issue of the Journal, only the original experi- 
ence of Gruentzig et al. (2) provided any long-term data. By 
1980 Gruentzig had performed the procedure on 169 symp- 
tomatic patients, 40% of whom had multivessel disease. 
When the follow-up of these patients extended to as long as 
10 years, he reported a 6 year actuarial survival of 93% 
following successful angioplasty with 90 patients (53%) 
remaining asymptomatic. Based on a mean follow-up time of 
9 years, which was 98% complete for 217 patients undergo- 
ing attempted angioplasty, Webb et al. report an actuarial 
survival of 97% at 5 years and 93% at 9 years. One hundred 
eighty-two patients (84%) were angina free at the end of the 
follow-up eriod; however, 39% of the cohort underwent 
subsequent coronary artery bypass urgery and 21% repeat 
coronary angioplasty. 
Considering the time frame of angioplasty in this series 
(1978 to 19811, the nearly 40% need for subsequent bypass 
surgery isnot as dreadful as it appears. With only 66% of the 
initial angioplasty procedures being successful, it was the 
rule in those days that unsuccessful but uncomplicated 
procedures (30%) were followed by early elective coronary 
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bypass urgery. Thus, of those patients undergoing success 
ful angioplasty only 16% required subsequent surgery. 
Implications of the study. Although many technologic 
advances have occurred since this cohort of patients under- 
went coronary angioplasty and the success rate of the 
procedure insimilar patients today could be expected to be 
>9tS-, there are many valuable lessons to be learned from 
this report. First, the major cardiac events complicating 
angioplasty have not changed substantially over a decade. 
The rate of emergency oronary surgery in this early series 
was 4%. procedural mortality 0.5% and Q wave infarction 
2%; these incidence rates are considered acceptable today 
even for single vessel angioplasty. 
It is also to be noted that although 87% of the study 
patients had single vessel disease (using a threshold of 70% 
vessel diameter narrowing), the majority had severe (class 
111 to IV) angina nd 95% had objective vidence of ischemia 
on exercise stress testing. Clearly this was a population that 
would have qualified for surgical revascularization at any 
time during the past wo decades. 
It is therefore appropriate hat the authors offer a com- 
parison between the 140 patients with successful angioplasty 
in their series and the 58 patients who underwent elective 
coronary bypass urgery within 2 months of their unsuccess- 
ful but uncomplicated angioplasty procedure. Even ac- 
knowledging certain limitations of this type of comparison, 
the similarity of outcomes is striking. After a decade of 
follow-up, the cardiac mortality was identical and impres- 
sively low (5%) in both groups. The incidence of subsequent 
myocardial infarction was also identical (9%) and the percent 
of patients free of angina was similar for both groups 
(angioplasty 85% versus urgery 86%). 
The need for a repeat revascularization procedure was 2.3 
times greater among the angioplasty-treated than in the 
surgically treated group. Although 75% of the time the repeat 
procedure was necessitated by restenosis, it is of interest 
that after 10 years of follow-up twice as many angioplasty- 
treated patients had undergone subsequent surgery as had 
surgically treated patients (16% versus 7%, p = 0.09). 
The most important conclusion to be drawn from this 
internal comparison of the treatment of similar patients with 
symptomatic single vessel disease and followed up for 10 
.vears is that, when successful, coronary angioplasty and 
surgery both provide superb long-term results. Management 
by either revascularization strategy results in an annual 
mortality rate that approximates 0.6%/year, a <I%/year 
likelihood of suffering a myocardial infarction and a s2.5%/ 
year likelihood of experiencing a major cardiac event (death, 
myocardial infarction or bypass urgery). 
Limitations ofthe study. It is equally important to recog- 
nize that there are two extrapolations that cannot be made 
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Although impressive, the long-term results of successful 
angioplasty in this series cannot be used to concl 
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